Relevant bibliographies by topics / Neuroborrelios

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Books
  4. Book chapters
  5. Conference papers

Academic literature on the topic 'Neuroborrelios'

Author: Grafiati
Published: 4 June 2021
Last updated: 1 February 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Neuroborrelios.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Neuroborrelios"

1

Wössner, R., and J. Treib. "Neuroborreliose." Nervenheilkunde 29, no. 05 (2010): 309–10. http://dx.doi.org/10.1055/s-0038-1628768.

Full text
Abstract:
ZusammenfassungIn Europa ist die Lyme-Borreliose die häufigste durch Zecken übertragene Erkrankung. Beim Erwachsenen ist die Meningoradikuloneuritis (Bannwarth-Syndrom) nach dem Erythema migrans die zweithäufigste Manifestation der akuten Borreliose. Zunächst können nächtlich betonte segmentale Schmerzen, zum Teil mit wechselnder Lokalisation auftreten. Weiterhin kann es zu Hirnnervenausfällen und anderen zentralen Manifestationen kommen. In späteren und chronischen Stadien kann eine Polyneuropathie oder Enzephalomyelitis auftreten. Die Behandlung der akuten Neuroborreliose erfolgt durch eine intravenöse antibiotische Therapie mit Cephalosporinen der dritten Generation oder Penizillin.
APA, Harvard, Vancouver, ISO, and other styles
2

Dersch, Rick, and Sebastian Rauer. "Neuroborreliose." Neurologie up2date 3, no. 03 (August 2020): 243–56. http://dx.doi.org/10.1055/a-1011-6634.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Kaiser, R., and V. Fingerle. "Neuroborreliose." Der Nervenarzt 80, no. 10 (June 19, 2009): 1239–51. http://dx.doi.org/10.1007/s00115-009-2788-z.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Spreer, A., S. Rauer, H. Wilking, and V. Fingerle. "Herausforderung Neuroborreliose." Der Nervenarzt 87, no. 12 (November 15, 2016): 1288–92. http://dx.doi.org/10.1007/s00115-016-0224-8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Dersch, Rick, and Volker Fingerle. "Lyme-Borreliose und Neuroborreliose – Was ist neu?" DMW - Deutsche Medizinische Wochenschrift 146, no. 11 (June 2021): 728–32. http://dx.doi.org/10.1055/a-1265-4397.

Full text
Abstract:
Was ist neu? Diagnostik Zellbasierte Verfahren (z. B. LTT, ELISPOT) sollten nicht für die Diagnosestellung einer Borreliose verwendet werden. Therapie Eine aktuelle randomisiert-kontrollierte Studie hat bestätigt, dass Doxycyclin- und Betalaktam-Antibiotika gleichwertig eingesetzt werden können. Es gibt keine statistisch signifikanten Unterschiede hinsichtlich neurologischer Symptome nach Therapie und Nebenwirkungen. Dementsprechend wird in der S3-Leitlinie Neuroborreliose kein Präparat bevorzugt empfohlen. Prognose Mehreren Studien mit Patienten mit antibiotisch behandelter Neuroborreliose zeigen im Langzeitverlauf keine erhöhte Rate an Fatigue im Vergleich zu gesunden Kontrollpersonen. Ebenso findet sich für Lebensqualität, Depression und Kognition kein Unterschied zwischen Patienten mit Neuroborreliose nach Antibiotikatherapie und gesunden Kontrollpersonen im Langzeitverlauf. Prophylaxe Eine prophylaktische Antibiotikagabe nach Zeckenstich wird derzeit in Deutschland nicht empfohlen.
APA, Harvard, Vancouver, ISO, and other styles
6

Dunin-Wąsowicz, Dorota, Beata Kasztelewicz, Katarzyna Tomaszek, Alicja Pawińska, Janusz Książyk, Anna Wieteska-Klimczak, Elżbieta Jurkiewicz, and Katarzyna Dzierżanowska-Fangrat. "Lyme Neuroborreliosis (LNB) – Clinical and Diagnostic Difficulties." Child Neurology 26, no. 53 (2017): 19–24. http://dx.doi.org/10.20966/chn.2017.53.406.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Dworzańska, Ewa, and Halina Bartosik-Psujek. "Neuroborreliosis." Reumatologia/Rheumatology 1 (2013): 63–67. http://dx.doi.org/10.5114/reum.2013.33397.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Halperin, John J. "Neuroborreliosis." Neurologic Clinics 36, no. 4 (November 2018): 821–30. http://dx.doi.org/10.1016/j.ncl.2018.06.006.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Halperin, John J. "Neuroborreliosis." American Journal of Medicine 98, no. 4 (April 1995): 52S—59S. http://dx.doi.org/10.1016/s0002-9343(99)80044-8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Halperin, John J. "Neuroborreliosis." Journal of Neurology 264, no. 6 (November 24, 2016): 1292–97. http://dx.doi.org/10.1007/s00415-016-8346-2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Neuroborrelios"

1

Knaziak, Margareta. "Utvärdering av C6-peptid-baserad serologi på cerebrospinalvätska som komplement vid diagnostik av neuroborrelios." Thesis, Linnéuniversitetet, Institutionen för naturvetenskap, NV, 2012. http://urn.kb.se/resolve?urn=urn:nbn:se:lnu:diva-20591.

Full text
Abstract:
Borrelios är den vanligaste fästingburna infektionen på norra halvklotet, och orsakas av spiroketer tillhörande Borrelia burgdorferi sensu lato-komplexet. Dessa bakterier kan spridas till flera organ och ge upphov till olika symptom i bland annat hud, nervsystem, leder och hjärta. Omkring 15 % utvecklar neurologiska symptom, så kallad neuroborrelios. Den bästa indikatorn på aktiv neuroborrelios är framförallt karakteristiska neurologiska symptom samt tecken på en inflammatorisk förändring i cerebrospinalvätskan (CSV) i kombination med lokalt producerade antikroppar mot Borrelia burgdorferi s.l. i CSV. Nuvarande metod för diagnostik av neuroborrelios är en immunokemisk metod, en ELISA (enzyme-linked immunosorbent assay) som bygger på en jämförelse av Borrelia-antikroppsnivåer i CSV och i serum genom beräkning av antikroppsindex (AI). Beräkning av AI kompenserar för en eventuell ospecifik överföring av antikroppar från serum, till följd av en skada på blod-hjärnbarriären. Det finns dock tecken på att den nuvarande analysmetoden har för låg sensitivitet med falskt negativa resultat, framförallt tidigt i infektionsförloppet. För diagnostik av andra former av borrelios än neuroborrelios används en typ av ELISA baserad på C6-peptid. C6-peptid ELISA visar god känslighet för detektion av B. burgdorferi s.l.-specifika antikroppar i serum. C6-antigenet utgör en starkt immunogen och konserverad region av bakteriens VlsE-ytprotein. Syftet med den här studien var att undersöka om detektion av antikroppar mot C6-peptid i CSV kan komplettera den nuvarande använda metoden och därmed förbättra den totala sensitiviteten för diagnostik av neuroborrelios. I studien analyserades 169 patientprover från unga personer, samt 18 oklara patientfall som tidigare bedömts negativa med den nuvarande metoden. Antikroppar mot C6-peptid detekterades hos åtta unga patienter samt två oklara patientfall. Av dessa hade åtminstone tre unga patienter sannolikt neuroborrelios. Resultat från den här studien tyder på att C6-peptid-ELISA på CSV-prover kan fungera som ett komplement till befintlig metod för diagnostik av neuroborrelios. En kombination av båda metoderna kan sannolikt ge en betydligt högre sensitivitet. Vid tolkning av resultat från C6-peptid-baserade analysmetoder på CSV ska hänsyn tas till eventuell ospecifik överföring av B. burgdorferi s.l.-specifika antikroppar genom blod-hjärnbarriären.
Lyme Borreliosis, caused by spirochetes of the Borrelia burgdorferi sensu lato-complex, is the most common tick-borne infection in the temperate regions of the northern hemisphere. The bacteria can infect many different organs, this can give rise to a variety of symptoms in skin, the nervous system, joints and heart. Approximately 15 % of the infected individuals show neurological symptoms referred to as neuroborreliosis. An active neuroborreliosis is indicated by inflammatory changes in the cerebrospinal fluid (CSF) and local synthesis of anti-Borrelia antibodies in CSF. The current method to diagnose neuroborreliosis is an enzyme-linked immunosorbent assay (ELISA) which compares levels of anti-Borrelia antibodies in CSF and serum by calculating an antibody index (AI). Calculations of AI compensate for unspecific leakage of antibodies from serum to CSF following an injury of the blood-brain barrier. The drawback of the current method is a low sensitivity with a high rate of false negative results in samples collected early during an infection. Another type of ELISA, based on the use of a C6 peptide, has earlier shown good sensitivity for detection of B. burgdorferi s.l.-specific antibodies in serum. The C6 antigen corresponds to a highly immunogenic and conserved region of the bacterial surface protein VlsE. The aim of this study was to investigate whether a detection of antibodies against the C6 peptide in CSF could improve the total sensitivity for the diagnostics of neuroborreliosis. In the current study, 169 samples with negative AI from young patients and 18 samples from special cases were analyzed. Antibodies against the C6 peptide were found in 8 young patients and in 2 samples from special cases. Out of these, 3 young patients were stated positive for neuroborreliosis. Results of this study show that the C6 peptide ELISA on CSF samples could act as a complement to the current serological method for diagnosing neuroborreliosis. A combination of both methods could possibly increase the overall sensitivity. However, the blod-brain barrier injury issue is a problem in the analysis and interpretation of the results of the C6 peptide-based method on CSF should take into consideration a possible dysfunction of the blood-brain barrier. In conclusion, a combination of both the current method and the C6 peptide ELISA could give a markedly improved sensitivity in diagnostics of neuroborreliosis.
APA, Harvard, Vancouver, ISO, and other styles
2

Woldu, Haddish Haben. "Analys av C3a och sC5b-9 med sandwich-ELISA för att mäta komplementaktivering vid subklinisk borrelios." Thesis, Linnéuniversitetet, Institutionen för kemi och biomedicin (KOB), 2018. http://urn.kb.se/resolve?urn=urn:nbn:se:lnu:diva-76120.

Full text
Abstract:
Lyme borreliosis (LB) is caused by spirocheter of Borrelia burgdorferi sensu lato. There are different types of borrelia species and some differ in their ability to survive in the presence of the complement system. B. afzelii is complementresistant while B. garinii is complementsensitive. This is based on the ability to recruit immune regulators, such as factor H to the bacterial surface and prevent activation of the complement system. Some individuals may show anti-Borrelia antibodies without having developed clinical symptoms. This may indicate a more effective immune response against spirochetes. The aim of this study was to investigate differences in complement activation by measuring C3a and sC5b-9 with sandwich ELISA between two previously Borrelia-exposed groups; individuals with previous subclinical Lyme borreliosis (SB) and patients previously diagnosed with neuroborreliosis (NB), and a control group without signs of LB exposure. Samples analyzed in this study consisted of controls (Ctrl, n = 8st), SB (n = 60st) and NB (n = 22st). Plasma from the groups were activated with ACA1 and Lu59. To compare the relative increase between the groups, complement factor C3a and the soluble terminal complement complex, sC5b-9, were analyzed using sandwich-ELISA.The analysis of C3a and sC5b-9 showed higher activation with Lu59 than ACA1, which is consistent with previous studies. According to C3a-analysis, no significant differences were observed between the groups for neither ACA1 nor Lu59. According to sC5b-9-analysis, a significant difference between SB and Ctrl (p= 0,0081) for Lu59 was observed. Conclusion of the studie was that further studies are required to interpret how this complement activation affects LB from a clinical prespective.
APA, Harvard, Vancouver, ISO, and other styles
3

Hedin, Skogman Barbro. "Neuroborreliosis in childhood : Clinical, immunological and diagnostic aspects." Doctoral thesis, Linköpings universitet, Pediatrik, 2008. http://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-11520.

Full text
Abstract:
Lyme Borreliosisis is a multi-organ infectious disease caused by the spirochete Borrelia burgdorferi. The spirochete is transmitted to humans by tick bites. Neuroborreliosis (NB) is a disseminated form of the disease, in which the spirochetes invade the nervous system. In children, subacute meningitis and facial nerve palsy are typical clinical manifestations of NB. The aim of this thesis was to study clinical, immunological and laboratory characteristics in children being evaluated for NB in a Lyme endemic area of Sweden, in order to identify factors of importance for prognosis and clinical recovery. A total of 250 patients and 220 controls were included during 1998-2005, with a prospective and a retrospective part. Less than half (41%) of children with signs and symptoms indicative of NB get the diagnosis confirmed by detection of Borrelia specific flagella antibodies in CSF (clinical routine method). Surprisingly few patients were diagnosed as having other infectious or neurologic diseases and consequently, many patients ended up with an uncertain diagnosis. However, four new Borrelia antigens (DbpA, BBK32, OspC, IR6) were evaluated and performed well in laboratory diagnostics. If they were combined in a panel, together with the flagella antigen, the sensitivity was 82% and the specificity 100%, leading to improved diagnostic accuracy in children with NB, as compared to using the routine flagella antibody test alone. Clinical recovery at the 6-month follow-up (n=177) was generally good and nonspecific symptoms, such as headache and fatigue, were not more frequently reported in patients than in controls. No patient was found to have recurrent or progressive neurologic symptoms. However, permanent facial nerve palsy was found in 22% of patients at the 2-year follow-up, with consequences such as eye-closing problems, excessive tear secretion, pronunciation difficulties and cosmetic complaints. When cellular immune responses were investigated, the number of Borrelia-specific IL-4 and IFN-γ secreting cells in CSF was found to be more prominent in children with NB than in controls. Furthermore, a much stronger IL-4 response in CSF was seen in children as compared to adults with NB. This cytokine profile of children with NB is believed to represent an effective and balanced type1/type2 response in a relevant compartment, and could contribute to the less severe course of the disease seen in children as compared to adults with NB. No prognostic factors were found to influence the outcome in patients with “Confirmed NB” or facial nerve palsy. Nor was any specific cytokine profile, or antibody response to new Borrelia antigens in CSF, correlated to a less favorable clinical outcome. An NB prediction score test, based on clinical variables at admission, is suggested to help physicians to determine whether to start early antibiotic treatment, before results from Borrelia antibody tests are available. Results in this thesis support the notion that mononuclear pleocytosis in CSF, in patients being evaluated for NB, indicates that they are true NB cases despite the fact that an antibody response cannot yet be visualized. with the routine flagella test. Consequently, early antibiotic treatment in NB seems to be the correct course of action and over-treatment is not a substantial problem.
Borrelia-infektion hos barn och vuxna är den vanligaste fästingburna infektionen i Sverige och orsakas av en bakterie som heter Borrelia burgdorferi. Den sprids till människa via fästingbett och kan orsaka besvär från hud, leder, hjärtmuskel och nervsystem. När nervsystemet är infekterat kallas det Neuroborrelios. Denna avhandling handlar om Neuroborrelios hos barn i syd-östra Sverige, ett område med hög Borrelia-förekomst. Jag har studerat symtom, laborativa provsvar och tillfrisknande hos 250 barn med misstänkt Neuroborrelios under åren 1998-2005 och jämfört med friska barn. Dessutom har jag tittat närmare på vissa signalsubstanser inom immunförsvaret i blod och ryggvätska och vilken roll signalsubstanserna spelar för förlopp och utläkning av infektionen. Avhandlingen innehåller också en utvärdering av fyra nya diagnostiska test vid misstänkt Neuroborrelios hos barn. Det visar sig att mindre än hälften (41%) av barnen med misstänkt Neuroborrelios får diagnosen säkerställd med det befintliga Borrelia-testet (baserat på ett protein som kallas flagellin) som används rutinmässigt. Dock förblir diagnosen oklar för många barn (59%). De fyra nya Borrelia-testen (baserade på protein som kallas DbpA, BBK32, OspC och IR6) visar sig fungera bra och om man kombinerar dem med befintligt Borrelia-test, kan man säkerställa Neuroborrelios hos 82% av barnen med misstänkt infektion. Jag hoppas att dessa nya Borrelia-test i framtiden kan leda till förbättrad diagnostik hos barn som utreds för misstänkt Neuroborrelios. Immunförsvarets signalsubstanser, som analyserades i ryggvätska och blod, visade sig ha en viss profil hos barn med Neuroborrelios jämfört med barn utan Borrelia-infektion, men även jämfört med vuxna med Neuroborrelios. De immunologiska T cellerna producerade två olika sorters signalsubstanser, som kallas ”Interferon-γ” och ”Interleukin-4”. Denna immunologiska profil verkar fördelaktig och kan möjligen bidra till den i allmänhet goda utläkning av Neuroborrelios som man ser hos barn jämfört med vuxna. De vanligaste symtomen vid en Borrelia-infektion i nervsystemet är huvudvärk, trötthet, dålig aptit, feber och ont i nacken. Ansiktsförlamning är det vanligaste specifika neurologiska symtomet. Antibiotikabehandling ges till 69% av barnen och vid en 6 månaders uppföljning rapporterar patienterna god utläkning av de olika symtomen. Inget barn hade återkommande eller allvarliga neurologiska symtom vid uppföljningen. Däremot, barn med ansiktsförlamning visade sig få kvarstående besvär i viss utsträckning. När de undersöktes 2 år efter sin ansiktsförlamning förekom mild till måttlig kvarstående förlamning i 22% av fallen. Patienterna uppgav besvär av ökat tårflöde, sluddrigt tal, svårigheter med att stänga ögat och dessutom rapporterade många patienter att snedheten i ansiktet var kosmetiskt störande. Inga specifika symtom, laborativa prov, immunologiska signalsubstanser eller diagnostiska test visade sig vara kopplade till ökad risk för kvarstående besvär efter Neuroborrelios i allmänhet och inte eller hos patienter med ansiktsförlamning. En checklista har utarbetats med olika symtom som är typiska för barn med Neuroborrelios. Den föreslås kunna användas som beslutsunderlag för start av tidig antibiotikabehandling, redan innan svar på Borrelia-testen finns tillgängliga.
APA, Harvard, Vancouver, ISO, and other styles
4

Schäfer, Claudia. "Vergleich der klinischen Variabilität der Neuroborreliose in Deutschland, Schweden und den USA." [S.l.] : [s.n.], 2000. http://deposit.ddb.de/cgi-bin/dokserv?idn=962827908.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Drenck, Kristina Elisabeth Philine [Verfasser], Holger [Akademischer Betreuer] Schmidt, and Ekkehard [Akademischer Betreuer] Wilichowski. "Langzeitfolgen der stattgehabten Neuroborreliose im Kindes- und Jugendalter / Kristina Elisabeth Philine Drenck. Gutachter: Holger Schmidt ; Ekkehard Wilichowski. Betreuer: Holger Schmidt." Göttingen : Niedersächsische Staats- und Universitätsbibliothek Göttingen, 2013. http://d-nb.info/1044736941/34.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Henningsson, Anna J. "Clinical, epidemiological and immunological aspects of Lyme borreliosis with special focus on the role of the complement system." Doctoral thesis, Linköpings universitet, Infektionsmedicin, 2011. http://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-71117.

Full text
Abstract:
Lyme borreliosis (LB) is the most common vector-borne disease in the Northern Hemisphere. The infection is caused by spirochetes belonging to the Borrelia burgdorferi sensu lato complex, and it is transmitted to humans by ticks. LB is associated with several clinical manifestations, of which erythema migrans (EM) and neuroborreliosis (NB) are the most common inEurope. The course of the disease is usually benign, but can vary between individuals. The underlying pathogenic mechanisms are not fully understood, but the prognosis is probably determined by a complex interplay between the bacteria and the host’s immune response. Previous studies have indicated that a strong initial T helper (Th) 1-response followed by a Th2 response is beneficial for the clinical outcome in LB. The aims of this thesis were to follow the incidence of NB inJönköping County,Sweden, over time, to search for clinical and laboratory markers associated with the risk of developing long-lasting post-treatment symptoms, and to explore the role of the complement system as well as the relative balance between Th-associated cytokine/chemokine responses in LB. The number of NB cases, diagnosed by cerebrospinal fluid (CSF) analysis, increased from 5 to 10/100,000 inhabitants/year in Jönköping County during 2000-2005. Post-treatment symptoms persisting more than 6 months occurred in 13 %, and were associated with higher age, longer-lasting symptoms prior to treatment, higher levels of Borrelia-specific IgG in CSF, and reported symptoms of radiculitis. Facial palsy, headache and fever were frequent manifestations in children, whereas unspecific muscle and joint pain were the most commonly reported symptoms in older patients. Complement activation occurred both locally in the skin in EM and in CSF of NB patients. However, no activation could be detected in blood in NB patients. Elevated levels of C1q, C4 and C3a in CSF, along with correlation between C1q and C3a levels, suggest complement activation via the classical pathway locally in the central nervous system in NB. In vitro experiments with two clinical Borrelia isolates revealed that B. garinii LU59 induced higher complement activation in human plasma compared to B. afzelii K78 that recruited more of complement regulator factor H. To elucidate the role of complement in the phagocytosis process, experiments were performed using whole blood from healthy donors incubated with fluorescence-labelled spirochetes and different complement inhibitors. The results illustrated a central role of complement for phagocytosis of Borrelia spirochetes. We also studied the relative contribution of different Th-associated cytokines/chemokine responses in NB. The results support the notion that early NB is dominated by a Th1 response, eventually accompanied by a Th2 response. IL-17A was increased in CSF in half of the patients with confirmed NB, suggesting a hitherto unknown role of Th17 in NB. In conclusion, the risk of developing long-lasting post-treatment symptoms tend to increase mainly with age and duration of symptoms prior to treatment in NB. The complement system seems to play an important role in host defence to recognize and kill Borrelia spirochetes. However, complement activation in inappropriate sites or to an excessive degree may cause tissue damage, and therefore, the role of complement in relation to disease course needs to be studied further. Likewise, the role of Th17 in LB pathogenesis and host defence should be further evaluated in prospective studies.
APA, Harvard, Vancouver, ISO, and other styles
7

Widhe, Mona. "Immune responses in human lyme borreliosis : cytokines and IgG subclasses in relation to clinical outcome /." Linköping : Univ, 2003. http://www.bibl.liu.se/liupubl/disp/disp2003/med778s.pdf.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Holmqvist, Stephanie. "Comparison of Two Methods for Detecting Intrathecal Synthesis of Borrelia Specific Antibodies." Thesis, Linnaeus University, School of Natural Sciences, 2010. http://urn.kb.se/resolve?urn=urn:nbn:se:lnu:diva-7868.

Full text
Abstract:

In Europe, Lyme disease is caused by the species Borrelia (B.) burgdorferi sensu stricto, B. garinii and B. afzelii. The disease is the most common vector-borne infection in Europe and the United States, and the resulting manifestation can involve the skin, nervous system, heart and joints. The symptoms that arise are associated with the Borrelia species causing the infection. The species most associated with neuroborreliosis is B. garinii whilst B. burgdorferi sensu stricto is associated with arthritis and B. afzelii is associated with dermatological symptoms. Lyme disease normally has three phases in untreated patients. The first phase is characterised by erythema migrans, a reddening of the skin around the area of the tick bite. If the disease develops to the second phase the patient will suffer from neuroborreliosis which is characterised by neurological symptoms such as headache and peripheral facial paralysis. Cerebrospinal fluid (CSF) analysis is used to diagnose neuroborreliosis. The diagnosis is complicated by variations between the different Borrelia species and that many healthy individuals have antibodies directed against Borrelia. Antibodies in CSF can be found in different diseases. The antibodies can be produced in the central nervous system or come across the blood-brain barrier and thus derive originally from the blood. By measuring the concentration of total albumin in serum and in CSF it can be determined if the antibodies present in the CSF have been produced in the central nervous system or if they originate from the blood. The typical manifestation in the last phase of Lyme disease is severe arthritis. The aim of this examination project was to compare two ELISAs for detection of antibodies directed to Borrelia. Indirect ELISAs from DAKO and Euroimmun were compared for the diagnosis of neuroborreliosis in 100 individuals. Borrelia specific antibodies of class IgM or IgG were found in 16 of 100 patients by DAKO’s ELISA and in 20 of the same 100 patients by Euroimmun’s ELISA. The reason that Euroimmun’s method detected more cases of neuroborreliosis is probably that this method detects antibodies directed to all three pathological species of Borrelia while DAKO’s method only detects antibodies directed to B. burgdorferi. In conclusion, this study indicates that Euroimmun’s method to detect antibodies of class IgM and IgG directed to Borrelia is superior to DAKO’s method. The obtained results were confirmed by Western blot analysis which gave results in accordance with those of Euroimmun’s ELISA.

APA, Harvard, Vancouver, ISO, and other styles
9

Jarefors, Sara. "Cytokine responses in human Lyme borreliosis : The role of T helper 1-like immunity and aspects of gender and co-exposure in relation to disease course." Doctoral thesis, Linköping : Univ, 2006. http://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-6120.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Brennauer, Konrad. "Prognose pädiatrischer Patienten nach Neuroborreliose." Doctoral thesis, 2007. http://hdl.handle.net/11858/00-1735-0000-0006-AF3E-5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Neuroborrelios"

1

Miller, Aaron E., and Teresa M. DeAngelis. Neuroborreliosis. Oxford University Press, 2013. http://dx.doi.org/10.1093/med/9780199732920.003.0008.

Full text
Abstract:
Neuroborreliosis, an infection of the nervous system by the spirochete Borrelia burgdorferi, is a controversial entity both in its proper diagnosis and management. In this chapter, we review the common presentations of Lyme infection affecting the central and peripheral nervous systems, the utility of diagnostic screening and confirmatory tests, and the recommended course of antibiotic treatment.
APA, Harvard, Vancouver, ISO, and other styles
2

Younger, David S. Human Lyme Neuroborreliosis. Nova Science Publishers, Incorporated, 2015.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Krause, Andreas, and Volker Fingerle. Lyme borreliosis. Oxford University Press, 2013. http://dx.doi.org/10.1093/med/9780199642489.003.0101.

Full text
Abstract:
Lyme borreliosis (LB) is a multisystem infectious disease caused by the tick-borne spirochete Borrelia burgdorferi. The most frequent clinical manifestations include erythema migrans, meningoplyneuritis, and arthritis. Diagnosis of LB is made on clinical grounds and usually supported by a positive serology. Early diagnosis and treatment almost always leads to a rapid healing of the disease. However, in late manifestations gradual remission of symptoms may take several weeks to months. In rare cases, the pathogen can persist for many years or induce a persisting immunopathological response that may cause acrodermatitis chronica atrophicans, chronic neuroborreliosis of the central nervous system, or antibiotic resistant Lyme arthritis. However, even these chronic manifestations usually slowly regress after thorough antibiotic and symptomatic therapy, although in part with irreversible organ defects.
APA, Harvard, Vancouver, ISO, and other styles
4

Krause, Andreas, and Volker Fingerle. Lyme borreliosis. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780199642489.003.0101_update_001.

Full text
Abstract:
Lyme borreliosis (LB) is a multisystem infectious disease caused by the tick-borne spirochete Borrelia burgdorferi. The most frequent clinical manifestations include erythema migrans, meningoplyneuritis, and arthritis. Diagnosis of LB is made on clinical grounds and usually supported by a positive serology. Early diagnosis and treatment almost always leads to a rapid healing of the disease. However, in late manifestations gradual remission of symptoms may take several weeks to months. In rare cases, the pathogen can persist for many years or induce a persisting immunopathological response that may cause acrodermatitis chronica atrophicans, chronic neuroborreliosis of the central nervous system, or antibiotic resistant Lyme arthritis. However, even these chronic manifestations usually slowly regress after thorough antibiotic and symptomatic therapy, although in part with irreversible organ defects.
APA, Harvard, Vancouver, ISO, and other styles

Book chapters on the topic "Neuroborrelios"

1

Reimers, Carl D. "Neuroborreliose." In Patienteninformationen Neurologie – Empfehlungen für Ärzte, 127–30. Berlin, Heidelberg: Springer Berlin Heidelberg, 2017. http://dx.doi.org/10.1007/978-3-662-53236-2_33.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Pankl, Wolfgang, and Thomas P. Bleck. "Neuroborreliosis." In Neurocritical Care, 428–32. Berlin, Heidelberg: Springer Berlin Heidelberg, 1994. http://dx.doi.org/10.1007/978-3-642-87602-8_40.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Halperin, John J. "Neuroborreliosis." In Meningitis and Encephalitis, 207–16. Cham: Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-92678-0_14.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Leung, Alexander K. C., William Lane M. Robson, Carsten Büning, Johann Ockenga, Janine Büttner, Hartmut Schmidt, Antonio V. Delgado-Escueta, et al. "Lyme Neuroborreliosis." In Encyclopedia of Molecular Mechanisms of Disease, 1223–25. Berlin, Heidelberg: Springer Berlin Heidelberg, 2009. http://dx.doi.org/10.1007/978-3-540-29676-8_3136.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Patrick, Erica, and Eric Logigian. "Lyme Neuroborreliosis." In Multiple Sclerosis and CNS Inflammatory Disorders, 169–77. Chichester, UK: John Wiley & Sons, Ltd., 2014. http://dx.doi.org/10.1002/9781118298633.ch17.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Kaiser, Reinhard. "Neuroborreliose und FSME." In Klinische Neurologie, 1217–29. Berlin, Heidelberg: Springer Berlin Heidelberg, 2020. http://dx.doi.org/10.1007/978-3-662-60676-6_101.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Kaiser, Reinhard. "Neuroborreliose und FSME." In Klinische Neurologie, 1–13. Berlin, Heidelberg: Springer Berlin Heidelberg, 2018. http://dx.doi.org/10.1007/978-3-662-44768-0_101-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Prange, H. W. "Neuroborreliose und Neurosyphilis." In Neurologische Intensivmedizin, 468–82. Berlin, Heidelberg: Springer Berlin Heidelberg, 1999. http://dx.doi.org/10.1007/978-3-642-58415-2_23.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Pfister, H. W., W. Kristoferitsch, and B. Sköldenberg. "Therapy of Lyme Neuroborreliosis." In Aspects of Lyme Borreliosis, 328–39. Berlin, Heidelberg: Springer Berlin Heidelberg, 1993. http://dx.doi.org/10.1007/978-3-642-77614-4_24.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Millner, M. M., R. R. Müllegger, and O. Wawschinek. "Transiente oligoklonale Liquorbanden bei Neuroborreliose (NB)." In Aktuelle Neuropädiatrie 1990, 327–31. Berlin, Heidelberg: Springer Berlin Heidelberg, 1991. http://dx.doi.org/10.1007/978-3-642-76833-0_47.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Neuroborrelios"

1

Siddiqui, N., N. Bethuel, and C. Magaspi. "Bilateral Diaphragmatic Paralysis: Rare Presentation of Neuroborreliosis." In American Thoracic Society 2020 International Conference, May 15-20, 2020 - Philadelphia, PA. American Thoracic Society, 2020. http://dx.doi.org/10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a6748.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Schmidt, Nele, Andreas Wegener-Panzer, and Kevin Rostasy. "P 336. Unusual Manifestation of Lyme Neuroborreliosis in Childhood and Adolescence." In Abstracts of the 44th Annual Meeting of the Society for Neuropediatrics. Georg Thieme Verlag KG, 2018. http://dx.doi.org/10.1055/s-0038-1675986.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Neuroborrelios' for particular source types:
Journal articles Dissertations / Theses
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography